Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Ruboxistaurin on Small Fiber Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must have Type 1 or Type 2 diabetes mellitus~* Patients must have bilateral sensorimotor distal peripheral neuropathy attributable to diabetes mellitus~* Patients must have blood glucose control measured as HbA1c=\<11%~* Patients must be 18 years of age or older.~* Patients must be able to return to all follow-up visits~Exclusion Criteria:~* Patients must not have symptoms of diabetic peripheral neuropathy that cannot be distinguished from other etiologies~* Patients must not have a neurologic disease or neuropathy from a cause other than diabetes mellitus that would interfere with correct evaluation of symptomatic peripheral neuropathy.~* Patient currently has uncontrolled high blood pressure~* You have other medical problems that your doctor feels would make it unsafe for you to participate in this study such as liver or kidney problems~* You are a woman of childbearing age and unwilling or unable to use effective contraceptive.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).